However, we observed that ibrutinib alone did not reduce BV2 microglial cell migration compared with vehicle (Additional?file?1: Determine S7), suggesting that ibrutinib itself may affect
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor